Moreover, COVID-19 patients were reported to have reduced NK cell functional markers such as CD107a+ (a degranulation marker), granzyme B, IFN-γ+, IL-2+, and TNF-α+ compared to healthy controls (Zheng et al., 2020). This evidence concerns the gene GZMB and COVID-19.